Mid-Atlantic BioTherapeutics Acquires XPose Therapeutics, Expanding Its Pipeline and Leadership Team

Mid-Atlantic BioTherapeutics, Inc. ("MABT") today announced the acquisition of XPose Therapeutics ("XPose"), a privately held biotechnology company focused on novel precision oncology therapeutics. The acquisition strengthens MABT's research platform and expands its small molecule and AI...